Announcement_1
Presenting OncoDIF and PRIME Model at ASH 2025 - our multi-agent framework for genomic curation and predictive relapse indicators for myeloma patients receiving T-cell engagers.
Presenting OncoDIF and PRIME Model at ASH 2025 - our multi-agent framework for genomic curation and predictive relapse indicators for myeloma patients receiving T-cell engagers.